Downregulation of the ERK 1 and 2 mitogen activated protein kinases using antisense oligonucleotides inhibits proliferation of porcine vascular smooth muscle cells

被引:23
作者
Fisher, M
Liu, B
Glennon, PE
Southgate, KM
Sale, EM
Sale, GJ
Lewis, MJ
Groves, PH
机构
[1] Univ Wales Coll Med, Wales Heart Res Inst, Cardiovasc Sci Res Grp, Cardiff CF4 4XN, S Glam, Wales
[2] Addenbrookes Hosp, Dept Cardiol, Cambridge, England
[3] Univ Bristol, Bristol Heart Inst, Bristol, Avon, England
[4] Univ Southampton, Dept Biochem, Southampton, Hants, England
基金
英国医学研究理事会;
关键词
protein kinases; second messengers; signal transduction; smooth muscle; vasculature; cell proliferation; antisense oligonucleotides;
D O I
10.1016/S0021-9150(00)00656-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The current model of the arterial response to injury suggests that proliferation of vascular smooth muscle cells is a central event. Mitogen activated protein kinases are part of the final common pathway of intracellular signalling involved in cell division and thus constitute an attractive target in attempting to inhibit this proliferation. We hypothesised that antisense oligonucleotides to mitogen activated protein kinase would inhibit serum induced smooth muscle cell proliferation by downregulating the protein. Porcine vascular smooth muscle cells were cultured and an antisense oligonucleotide sequence against the ERK family of mitogen activated protein kinases (AMK1) was introduced by liposomal transfection. Sense oligonucleotides and a random sequence were used as controls. Proliferation was inhibited by AMK1 versus the sense controls, as assessed by tritiated thymidine incorporation (P < 0.01). Immunoblots revealed downregulation of the target protein by AMK1 by 63% versus the sense control (P < 0.05). In conclusion, antisense oligonucleotides specifically inhibited proliferation and downregulated the target protein. This is consistent with a central role for mitogen activated protein kinases in Vascular smooth muscle cell proliferation in the porcine model. In addition, the data suggest a possible role for antisense oligonucleotides in the modulation of the arterial injury response. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:289 / 295
页数:7
相关论文
共 35 条
[1]   Antithrombotic potential of polymer-coated stents eluting platelet glycoprotein IIb/IIIa receptor antibody [J].
Aggarwal, RK ;
Ireland, DC ;
Azrin, MA ;
Ezekowitz, MD ;
deBono, DP ;
Gershlick, AH .
CIRCULATION, 1996, 94 (12) :3311-3317
[2]  
BALCON R, 1992, CIRCULATION, V86, P100
[3]   ANTISENSE THERAPY FOR ANGIOPLASTY RESTENOSIS - SOME CRITICAL CONSIDERATIONS [J].
BENNETT, MR ;
SCHWARTZ, SM .
CIRCULATION, 1995, 92 (07) :1981-1993
[4]   SELECTION OF SINGLE-STRANDED-DNA MOLECULES THAT BIND AND INHIBIT HUMAN THROMBIN [J].
BOCK, LC ;
GRIFFIN, LC ;
LATHAM, JA ;
VERMAAS, EH ;
TOOLE, JJ .
NATURE, 1992, 355 (6360) :564-566
[5]   THE BIOLOGY OF SAPHENOUS-VEIN GRAFT OCCLUSION - ETIOLOGY AND STRATEGIES FOR PREVENTION [J].
BRYAN, AJ ;
ANGELINI, GD .
CURRENT OPINION IN CARDIOLOGY, 1994, 9 (06) :641-649
[6]   THE HEPARIN-BINDING (FIBROBLAST) GROWTH-FACTOR FAMILY OF PROTEINS [J].
BURGESS, WH ;
MACIAG, T .
ANNUAL REVIEW OF BIOCHEMISTRY, 1989, 58 :575-606
[7]  
Camenzind E, 1996, Semin Interv Cardiol, V1, P67
[8]   ELIMINATION OF SMOOTH-MUSCLE CELLS IN EXPERIMENTAL RESTENOSIS - TARGETING OF FIBROBLAST GROWTH-FACTOR RECEPTORS [J].
CASSCELLS, W ;
LAPPI, DA ;
OLWIN, BB ;
WAI, C ;
SIEGMAN, M ;
SPEIR, EH ;
SASSE, J ;
BAIRD, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (15) :7159-7163
[9]  
Castier Y, 1998, J CARDIOVASC SURG, V39, P1
[10]   Inhibition of intimal hyperplasia by an antisense oligonucleotide of farnesyl transferase delivered endoluminally during iliac angioplasty in a rabbit model [J].
Chemla, E ;
Castier, Y ;
Julia, P ;
Pirotski, E ;
Carpentier, A ;
Fabiani, JN .
ANNALS OF VASCULAR SURGERY, 1997, 11 (06) :581-587